全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

浅析金天格胶囊联合其他药物治疗骨质疏松的研究进展
The Research Progress of Jintiange Capsule Combined with Other Drugs in the Treatment of Osteoporosis

DOI: 10.12677/acm.2025.153845, PP. 2115-2119

Keywords: 金天格胶囊,骨质疏松,联合
Jintiange Capsule
, Osteoporosis, Combination

Full-Text   Cite this paper   Add to My Lib

Abstract:

骨质疏松症(Osteoporosis)是一种全身性骨病,特征是骨密度降低、骨质量减少及骨微结构受损,导致骨骼变得脆弱并容易发生骨折。虽然中医学没有直接使用“骨质疏松”这一病名,但根据其临床表现,该病症可归入“骨痹”、“骨痿”等传统分类中。中医理论认为,该病的发生与气血失调、五脏虚损密切相关,导致肢体筋脉失养、经络闭阻,从而引发疼痛等症状。因此,中医治疗通常以补肾健脾、疏肝理气为基本原则,通过辨证取得显著疗效。金天格胶囊的主要成分是人工虎骨粉,研究表明,与其他骨质疏松症疗法联合使用,可显著提高治疗效果。从人口结构来看,截至2022年,50至69岁的人群约有4.1亿人;25至39岁的人群约为3.2亿人;40至50岁的人群约为2亿人;10至25岁的青少年儿童则有约2.2亿人。近年来少儿人口比例有所回升,这表明生育政策的调整已经产生了积极效果。同时,人口老龄化程度进一步加深,骨质疏松患者在骨科疾病中会急剧上升。金天格胶囊作为一种治疗骨质疏松的要药经常与其他治疗联合使用,故本文将从文献搜集资料进行整理进行浅析。
Osteoporosis is a systemic bone disease characterized by reduced bone density, reduced bone mass and damaged bone microstructure, which can make bones brittle and prone to fracture. Although traditional Chinese medicine does not directly use the name “osteoporosis”, according to its clinical manifestations, the disease can be classified into traditional categories such as “bone arthralgia” and “bone potence”. According to the theory of traditional Chinese medicine, the occurrence of the disease is closely related to the disorder of Qi and blood and the deficiency of the five viscera, which leads to the loss of the limbs and the blockage of the meridians, thus causing pain and other symptoms. Therefore, TCM treatment is usually based on the basic principles of tonifying kidney and spleen, soothing liver and regulating qi, and has achieved remarkable curative effect through syndrome differentiation. The main component of Jintiange capsule is artificial tiger bone meal, and studies have shown that it can significantly improve the therapeutic effect when combined with other osteoporosis therapies. In terms of population structure, as of 2022, there were approximately 410 million people aged 50 to 69; about 320 million people aged 25 to 39; around 200 million people aged 40 to 50; and roughly 220 million children and adolescents aged 10 to 25. In recent years, the proportion of children has rebounded, which indicates that the adjustment of the birth policy has produced positive results. At the same time, the degree of aging of the population is further deepened, and the number of patients with osteoporosis will rise sharply in orthopedic diseases. As an important drug for osteoporosis, Jintiange capsule is often used in combination with other treatments, so this paper will sort out and analyze the data collected from the literature.

References

[1]  刘辽, 程玲, 龙莹莹, 等. 金天格胶囊治疗原发性骨质疏松的系统评价[J]. 中成药, 2018, 40(11): 2606-2612.
[2]  卢广民, 周生艳, 徐剡. 降钙素联合骨化三醇胶丸对糖尿病合并骨质疏松症的影响[J]. 中国骨质疏松杂志, 2019, 25(1): 103-106.
[3]  巫彬彬, 彭济河, 林彩龙, 等. 经皮椎体成形术联合鲑鱼降钙素治疗老年骨质疏松胸腰椎压缩性骨折的疗效观察[J]. 黑龙江医药, 2018, 31(2): 324-326.
[4]  仇志韬, 杨辉, 王文革, 秦国强, 张冰冰. 金天格胶囊联合骨化三醇对骨质疏松性椎体压缩性骨折患者的应用效果分析[J]. 河北医学, 2022, 28(9): 1573-1577.
[5]  邓晓君. 金天格胶囊联合鲑降钙素对老年性骨质疏松症骨代谢及骨密度的影响[J]. 中国校医, 2022, 36(1): 38-40.
[6]  吴洋洋, 刘高熊, 李敬祥. 金天格胶囊联合经皮椎体后凸成形术治疗骨质疏松脊柱压缩性骨折疗效观察及对骨密度的影响[J]. 新中医, 2021, 53(22): 93-96.
[7]  卢凌剑. 辛伐他汀和鲑降钙素注射液联合金天格胶囊治疗老年骨质疏松性I度胸腰椎压缩性骨折的临床疗效[J]. 临床合理用药杂志, 2021, 14(6): 44-45, 48.
[8]  吉秋霞, 管义祥, 徐建华. 金天格胶囊联合伊班膦酸钠及碳酸钙对骨质疏松患者的临床观察[J]. 中国药师, 2021, 24(6): 1102-1104, 1192.
[9]  王瑞瑞. 唑来膦酸注射液联合金天格胶囊治疗绝经后骨质疏松症疗效分析[J]. 医学信息, 2018, 31(17): 132-134.
[10]  于红光. 健脾补骨汤联合金天格胶囊对骨质疏松性疼痛患者骨代谢指标及疼痛程度的影响[J]. 新中医, 2022, 54(11): 134-137.
[11]  丁杰, 乔旭霞. 仙灵骨葆胶囊联合金天格胶囊治疗股骨干骨折骨质疏松症疗效观察[J]. 西部中医药, 2019, 32(1): 74-76.
[12]  王海峰. 金天格胶囊联合云南白药治疗骨质疏松症疗效研究[J]. 世界最新医学信息文摘, 2016, 16(72): 184.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133